Article
Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives
1 Jan 2011
Abstract excerpt
Pancreatic cancer remains stubbornly resistant to many key cytotoxic chemotherapeutic agents and novel targeted therapies. The molecular heterogeneity of this cancer may account for therapy failures to date, although our growing arsenal of novel targeted agents could translate into patient survival. The main objectives of this review are to elucidate histological subtypes of pancreatic neoplasms that exhibit the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
